| Metric | FY 2021 | Prior Q | FY 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $14.2B | — | — | — | — |
| Op. Income | $4.1B | — | — | — | — |
| Gross Margin | 75.4% | — | — | — | — |
| Net Margin | 21.0% | — | — | — | — |
| EPS (Diluted) | $7.35 | — | — | — | — |
| Free Cash Flow | -$1.7B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $14.2B |
| Cost of Revenue | $3.5B |
| GROSS PROFIT | $10.7B |
| R&D Expenses | $0 |
| Selling & Marketing | $142M |
| General & Administrative | $4.1B |
| SG&A Expenses | $4.2B |
| Other Expenses | $2.3B |
| Operating Expenses | $6.6B |
| Cost & Expenses | $10.1B |
| OPERATING INCOME | $4.1B |
| Interest Income | $10.3B |
| Interest Expense | $2.7B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $4.1B |
| Income Tax Expense | $1.1B |
| Net Income from Continuing Ops | $3.0B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $3.0B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $3.0B |
| D&A | $680M |
| EBIT | $4.1B |
| EBITDA | $4.8B |
| EPS | $8 |
| EPS Diluted | $7 |
| Item | Amount |
|---|---|
| REVENUE | $14.2B |
| Cost of Revenue | $3.5B |
| GROSS PROFIT | $10.7B |
| R&D Expenses | $0 |
| Selling & Marketing | $142M |
| General & Administrative | $4.1B |
| SG&A Expenses | $4.2B |
| Other Expenses | $2.3B |
| Operating Expenses | $6.6B |
| Cost & Expenses | $10.1B |
| OPERATING INCOME | $4.1B |
| Interest Income | $10.3B |
| Interest Expense | $2.7B |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $4.1B |
| Income Tax Expense | $1.1B |
| Net Income from Continuing Ops | $3.0B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $3.0B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $3.0B |
| D&A | $680M |
| EBIT | $4.1B |
| EBITDA | $4.8B |
| EPS | $8 |
| EPS Diluted | $7 |
| Item | Amount |
|---|---|
| Net Income | $3.0B |
| Depreciation & Amortization | $680M |
| Stock-Based Compensation | $69M |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $3.0B |
| Change in Working Capital | -$8.1B |
| OPERATING CASH FLOW | -$1.4B |
| Capital Expenditure | -$323M |
| Acquisitions (Net) | $253M |
| Purchases of Investments | -$46.7B |
| Sales/Maturities of Investments | $44.1B |
| Other Investing Activities | -$29M |
| NET CASH FROM INVESTING | -$2.6B |
| Net Debt Issuance | $7.6B |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$663M |
| Other Financing Activities | $322M |
| NET CASH FROM FINANCING | $7.3B |
| FREE CASH FLOW | -$1.7B |
| Net Change in Cash | $3.5B |
| Item | Amount |
|---|---|
| Cash & Equivalents | $21.4B |
| Short-Term Investments | $40.8B |
| Net Receivables | $67M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $62.4B |
| PP&E (Net) | $3.5B |
| Goodwill | $544M |
| Intangible Assets | $662M |
| Long-Term Investments | $363.1B |
| Tax Assets | $107M |
| Other Non-Current Assets | $12.3B |
| TOTAL NON-CURRENT ASSETS | $380.2B |
| TOTAL ASSETS | $442.6B |
| Account Payables | $23M |
| Short-Term Debt | $9.7B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $262.7B |
| TOTAL CURRENT LIABILITIES | $274.8B |
| Long-Term Debt | $83.9B |
| Deferred Revenue NC | $588M |
| Deferred Tax Liabilities | $1.3B |
| Other Non-Current Liabilities | $48.3B |
| TOTAL NON-CURRENT LIABILITIES | $134.5B |
| TOTAL LIABILITIES | $409.3B |
| Common Stock | $1.4B |
| Additional Paid-In Capital | $11.4B |
| Retained Earnings | $17.8B |
| Treasury Stock | -$767M |
| Accum. Other Comp. Income | $934M |
| Other Equity | $1.9B |
| TOTAL STOCKHOLDERS' EQUITY | $32.8B |
| Minority Interest | $563M |
| TOTAL EQUITY | $33.3B |
| TOTAL LIABILITIES & EQUITY | $442.6B |
| Total Debt | $94.0B |
| Net Debt | $72.6B |
